1. Home
  2. MAMA vs CBIO Comparison

MAMA vs CBIO Comparison

Compare MAMA & CBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAMA
  • CBIO
  • Stock Information
  • Founded
  • MAMA 2010
  • CBIO 2003
  • Country
  • MAMA United States
  • CBIO United States
  • Employees
  • MAMA N/A
  • CBIO N/A
  • Industry
  • MAMA Specialty Foods
  • CBIO
  • Sector
  • MAMA Consumer Staples
  • CBIO
  • Exchange
  • MAMA Nasdaq
  • CBIO Nasdaq
  • Market Cap
  • MAMA 323.1M
  • CBIO 308.0M
  • IPO Year
  • MAMA N/A
  • CBIO N/A
  • Fundamental
  • Price
  • MAMA $7.98
  • CBIO $14.29
  • Analyst Decision
  • MAMA Strong Buy
  • CBIO Strong Buy
  • Analyst Count
  • MAMA 3
  • CBIO 5
  • Target Price
  • MAMA $10.33
  • CBIO $25.60
  • AVG Volume (30 Days)
  • MAMA 154.7K
  • CBIO 98.3K
  • Earning Date
  • MAMA 09-08-2025
  • CBIO 07-31-2025
  • Dividend Yield
  • MAMA N/A
  • CBIO N/A
  • EPS Growth
  • MAMA N/A
  • CBIO N/A
  • EPS
  • MAMA 0.11
  • CBIO N/A
  • Revenue
  • MAMA $128,745,000.00
  • CBIO N/A
  • Revenue This Year
  • MAMA $17.24
  • CBIO N/A
  • Revenue Next Year
  • MAMA $9.95
  • CBIO N/A
  • P/E Ratio
  • MAMA $72.57
  • CBIO N/A
  • Revenue Growth
  • MAMA 17.04
  • CBIO N/A
  • 52 Week Low
  • MAMA $5.50
  • CBIO $10.83
  • 52 Week High
  • MAMA $9.98
  • CBIO $21.40
  • Technical
  • Relative Strength Index (RSI)
  • MAMA 41.43
  • CBIO 52.92
  • Support Level
  • MAMA $8.37
  • CBIO $13.50
  • Resistance Level
  • MAMA $8.74
  • CBIO $16.00
  • Average True Range (ATR)
  • MAMA 0.31
  • CBIO 0.79
  • MACD
  • MAMA -0.00
  • CBIO 0.16
  • Stochastic Oscillator
  • MAMA 10.11
  • CBIO 39.68

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About CBIO Crescent Biopharma Inc. Common Stock

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

Share on Social Networks: